Prevalence of chronic hepatitis B virus infection and infrastructure for its diagnosis in Madagascar: implication for the WHO’s elimination strategy-Reference-Cited by-同舟云学术

Prevalence of chronic hepatitis B virus infection and infrastructure for its diagnosis in Madagascar: implication for the WHO’s elimination strategy

Published:2017-08-04 Issue:1 Volume:17 Page:
ISSN:1471-2458
Container-title:BMC Public Health
language:en
Short-container-title:BMC Public Health

Author:

Andriamandimby Soa Fy^ORCID,Olive Marie-Marie,Shimakawa Yusuke,Rakotomanana Fanjasoa,Razanajatovo Iony Manitra,Andrianinarivomanana Tsarasoa Malala,Ravalohery Jean-Pierre,Andriamamonjy Seta,Rogier Christophe,Héraud Jean-Michel

Publisher

Springer Science and Business Media LLC

Subject

Public Health, Environmental and Occupational Health

Link

http://link.springer.com/content/pdf/10.1186/s12889-017-4630-z.pdf

Reference33 articles.

1. Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386(10003):1546–55.

2. Shimakawa Y, Lemoine M, Njai HF, Bottomley C, Ndow G, Goldin RD, Jatta A, Jeng-Barry A, Wegmuller R, Moore SE, et al. Natural history of chronic HBV infection in West Africa: a longitudinal population-based study from the Gambia. Gut. 2016;65(12):2007–2016.

3. Jemal A, Bray F, Forman D, O'Brien M, Ferlay J, Center M, Parkin DM. Cancer burden in Africa and opportunities for prevention. Cancer. 2012;118(18):4372–84.

4. WHO: Draft global health sector strategies. Viral hepatitis, 2016–2021. 2015.

5. Lemoine M, Shimakawa Y, Njie R, Taal M, Ndow G, Chemin I, Ghosh S, Njai HF, Jeng A, Sow A, et al. Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in the Gambia: the prevention of liver fibrosis and cancer in Africa (PROLIFICA) study. Lancet Glob Health. 2016;4(8):e559–67.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating the impact of COVID-19 outbreak on hepatitis B and forecasting the epidemiological trend in mainland China: a causal analysis;BMC Public Health;2024-01-02

2. Enjeux et difficultés de l'accès aux traitements pour la prise en charge de l'hépatite B chronique à Madagascar : étude qualitative auprès des soignants et personnes atteintes;Revue d'Épidémiologie et de Santé Publique;2023-08

3. Mac-2 binding protein glycosylation isomer (M2BPGi) to evaluate liver fibrosis and cancer in HBV-infected patients in West Africa;Journal of Global Health;2022-11-12

4. Undiagnosed Seroprevalence of Hepatitis B and C Virus Infections in the Community of Wolaita Zone, Southern Ethiopia;Hepatic Medicine: Evidence and Research;2022-08

5. Tunable Duplex Semiquantitative Detection of Nucleic Acids with a Visual Lateral Flow Immunoassay Readout;Analytical Chemistry;2022-02-24